Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“Two-thirds of HSCT survivors develop at least one chronic health condition; while a fifth develop severe or life-threatening conditions.” Dear David- I am a newly diagnosed multiple myelomaContinue reading
“This is the first study that puts chemo brain on a sound scientific footing, in terms of neurobiology and cellular biology.” After years of denials, excuses and stalling from conventional oncologyContinue reading
“The challenge for those newly diagnosed Multiple Myeloma patients that achieve remission is that the toxicity of those therapies can cause life-threatening side effects to the patient’s blood,Continue reading
“MM is a blood cancer that combines potentially life-threatening symptoms and a series of life-threatening side effects. All at the same time.” “Hi David. I am grateful to have foundContinue reading
“Multiple myeloma is associated with a significant risk of venous thromboembolism (VTE-blood clot), causing substantial levels of morbidity and mortality.” Thick blood, documented by a highContinue reading
“High plasma levels of the kinds of fatty acids found in fish oil were associated with a lower long-term risk for new heart failure (HF), whether with reduced or preserved ejection fraction…” IContinue reading
Greater magnesium intake was significantly related to higher Bone Mineral Density (BMD) in white women and men… Because about 90% of multiple myeloma patients and survivors will experience lyticContinue reading
“Once HF symptoms appear (stage C HF) in patients with reduced LVEF, the risk for progression to stage D HF increases, with a recent study of 964 HF with reduced EF patients…” I am aContinue reading
“Our study suggests that EPA and DHA (omega-3 fatty acids) induce selective cytotoxic effects in Multiple Myeloma and increase sensitivity to Velcade (bortezomib).” Multiple myeloma, the bloodContinue reading